Athos Therapeutics

aid: athos-therapeutics
name: Athos Therapeutics
description: Athos Therapeutics is a clinical-stage biopharmaceutical company in Torrance, California developing precision
  small-molecule therapeutics for autoimmune and chronic inflammatory diseases, led by co-founder and CEO Dr. Dimitrios Iliopoulos.
  Its AI/ML discovery platform integrates multi-omic patient data — genomics, transcriptomics, proteomics, epigenomics, metabolomics
  and microbiomics — collected with global hospital systems to identify novel drug and gene targets, and produced ATH-063,
  an AI-generated G9A methyltransferase inhibitor advancing in inflammatory bowel disease. The computational side of the business
  is commercialized through Chiron AI Labs (formerly AthosOmics.AI), a deliberately no-code omics analysis SaaS suite (Athos-Multi,
  Athos-T, Athos-P, Athos-G, Athos-PM) that is pre-launch and gated behind a demo waitlist. Athos publishes no public API,
  developer portal, SDK or machine-readable specification.
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: approval
  trial: false
  try_now: false
  public: false
  label: Requires approval
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://athostx.com/wp-content/uploads/2020/04/athos-favicon.jpg
url: https://raw.githubusercontent.com/api-evangelist/athos-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Artificial Intelligence
- Machine-Learning
- Genomics
- Precision Medicine
- Health
tags_raw:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Genomics
- Precision Medicine
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/athos-therapeutics-domain-security.yml
- type: Website
  url: https://athostx.com/
- type: Blog
  url: https://athostx.com/news-posts/
- type: BlogRSS
  url: https://athostx.com/feed/
- type: Support
  url: https://athostx.com/contact/
- type: Careers
  url: https://athostx.com/careers/
- type: Team
  url: https://athostx.com/ourteam/
- type: Product
  url: https://chironailabs.com/our-products
- type: Company
  url: https://chironailabs.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/athostx
- type: Twitter
  url: https://twitter.com/athostx
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Athos is a clinical-stage biotech whose only software product, the Chiron AI Labs omics suite (formerly AthosOmics.AI),
    is marketed explicitly as "no-code" and is pre-launch behind a demo-waitlist email form; the eight-page athostx.com sitemap
    contains no developer, docs or API page and every well-known/spec path on both hosts returns 404.
  evidence:
  - url: https://athostx.com/page-sitemap.xml
    status: 200
  - url: https://athostx.com/openapi.json
    status: 404
  - url: https://athostx.com/.well-known/agent-card.json
    status: 404
  - url: https://chironailabs.com/openapi.json
    status: 404
  - url: https://chironailabs.com/llms.txt
    status: 404
  - url: https://api.athostx.com/
    status: 0
  checked: '2026-08-06'